The Hospital Israelita Albert Einstein is a Brazilian hospital, located in the Morumbi district, on the south side of São Paulo. It is considered one of the best hospitals in Latin America.

During the past decade, Hospital Israelita Albert Einstein conducted 88 clinical trials. In the 10-year time frame, 88 clinical trials started and 15 clinical trials were completed, i.e. on average, 17% percent of trials that started reached the finish line to date. In the past 5 years, 48 clinical trials started and 7 clinical trials were completed. i.e. 14.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Israelita Albert Einstein" #1 sponsor was "Hospital Israelita Albert Einstein" with 60 trials, followed by "Janssen Research & Development, LLC" with 9 trials sponsored, "Pfizer" with 5 trials sponsored, "Takeda" with 5 trials sponsored and "Bayer" with 5 trials sponsored. Other sponsors include 41 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Israelita Albert Einstein" #1 collaborator was "Hospital Israelita Albert Einstein" with 8 trials as a collaborator, "Brazilian Research In Intensive Care Network" with 6 trials as a collaborator, "Fundação de Amparo à Pesquisa do Estado de São Paulo" with 6 trials as a collaborator, "Hospital Sirio-Libanes" with 5 trials as a collaborator and "Hospital do Coracao" with 5 trials as a collaborator. Other collaborators include 56 different institutions and companies that were collaborators in the rest 50 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Israelita Albert Einstein" are "Coronary Artery Disease" (5 trials), "Multiple Myeloma" (5 trials), "Crohn's Disease" (4 trials), "Emotional Stress" (4 trials) and "Covid19" (3 trials). Many other conditions were trialed in "Hospital Israelita Albert Einstein" in a lesser frequency.

Most popular intervention types in "Hospital Israelita Albert Einstein" are "Drug" (55 trials), "Other" (23 trials), "Behavioral" (15 trials), "Procedure" (11 trials) and "Device" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Dexamethasone" (5 trials), "Bortezomib" (3 trials), "Cyclophosphamide" (3 trials) and "Flourishing App Program" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Israelita Albert Einstein" are 115 trials for "All" genders, 8 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are 42 active trials in "Hospital Israelita Albert Einstein". 4 are not yet recruiting, 28 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 59 completed trials in Hospital Israelita Albert Einstein, 2 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Israelita Albert Einstein, 2 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 41 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 36 trials that are defined as “Not Applicable".